Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker '26: Neomorph, Oricell & more
Welcome to Fierce Biotech’s Fundraising Tracker for 2026.
Will Maddox
,
Darren Incorvaia
,
James Waldron
,
Gabrielle Masson
Apr 13, 2026 9:50am
'Can it deliver?': Why Big Pharma has entered the quantum realm
Apr 10, 2026 7:20am
China’s Oricell raises $110M for CAR-T plans ahead of IPO push
Apr 10, 2026 4:11am
OrbiMed’s Sidewinder slithers ahead with $137M series B for ADCs
Apr 8, 2026 7:00am
Jeito's $1.2B ‘largest ever’ for independent Euro biopharma fund
Apr 8, 2026 5:01am
Syneron closes $150M round to support peptide platform
Apr 3, 2026 9:31am